category,datetime,headline,id,image,related,source,summary,url
company,1769467802,Amgen (AMGN) Laps the Stock Market: Here's Why,138266048,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,AMGN,Yahoo,"In the most recent trading session, Amgen (AMGN) closed at $349.69, indicating a +1.43% shift from the previous trading day.",https://finnhub.io/api/news?id=467b2c368bf64c25125fc213aef9c84647a380e122f336ff77cc999370527ab7
company,1769436326,Viridian Therapeutics: Cautious Optimism As Key Milestones Approach (Rating Downgrade),138264105,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2016447711/image_2016447711.jpg?io=getty-c-w1536,AMGN,SeekingAlpha,"Viridian Therapeutics has surged on thyroid eye disease wins, big growth forecasts, and improved funding ahead of the FDA rollout. Read the VRDN stock update.",https://finnhub.io/api/news?id=321c1dcae94223a4da773a034661eb2dea6768a882b5d80b27b0395dd7703ee4
company,1769428813,Amgen's (NASDAQ:AMGN) 11% CAGR outpaced the company's earnings growth over the same five-year period,138261277,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,AMGN,Yahoo,"If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...",https://finnhub.io/api/news?id=0e269c7901eed9bb09683e38eb13be6990ff144369465d7e606b53002a9df75b
company,1769398274,Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks,138260421,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,AMGN,Yahoo,"As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Amgen (NASDAQ:AMGN) and its peers.",https://finnhub.io/api/news?id=f8ea5d8c6c21d2ee50cd09a0c1aa88f6a1170df026674402da797d8236ad376f
